Login / Signup
Prolactinomas and menopause: any changes in management?
Yona Greenman
Published in:
Pituitary (2020)
There is no evidence that justifies changing current recommendations to withhold medical treatment of microprolactinomas in asymptomatic post-menopausal women. Macroprolactinoma patients should be treated according to standard clinical practice.
Keyphrases
</>
clinical practice
end stage renal disease
ejection fraction
healthcare
chronic kidney disease
peritoneal dialysis
type diabetes
postmenopausal women
metabolic syndrome
pregnant women
adipose tissue
pregnancy outcomes
insulin resistance
patient reported